Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders Equity (Deficiency)

v3.20.1
Consolidated Statements of Changes in Stockholders Equity (Deficiency) - USD ($)
Common Stock
Additional Paid-In Capital
Accumlated Other Comprehensive Income
Accumulated Deficit
Total
Beginning Balance, Shares at Dec. 31, 2016 9,252,323        
Beginning Balance, Amount at Dec. 31, 2016 $ 925 $ 14,171,838 $ (416,631) $ 11,263,540 $ 2,492,628
Cumulative effect of restatement on prior periods     489,027 (460,887) 28,140
Restated beginning balance, shares at Dec. 31, 2016 9,252,323        
Restated beginning balance, amount at Dec. 31, 2016 $ 925 14,171,838 72,396 (11,724,391) 2,520,768
Shares issued for services, shares 15,625        
Stock issued for services $ 2 23,248     23,250
Imputed interest on stock advances   26,753     26,753
Beneficial conversion value of debt   39,231     39,231
Common stock issued with debentures        
Foreign currency translation adjustment     54,216   54,216
Net income (loss)       1,451,084 1,451,084
Ending Balance, Shares at Dec. 31, 2017 9,267,948        
Ending Balance, Amount at Dec. 31, 2017 $ 927 14,261,070 126,612 (10,273,307) 4,115,302
Adoption of ASU 2017-11   287,881   (64,966) 222,915
Ending Balance, Shares at Dec. 31, 2017 9,267,948        
Ending Balance, Amount at Dec. 31, 2017 $ 927 14,548,951 126,612 (10,338,273) 4,338,217
Restated beginning balance, amount at Dec. 31, 2017 $ 927 14,548,951 126,612 (10,338,273) 4,338,217
Imputed interest on stock advances   1,514     1,514
Shares issued for warrants, shares 25,136        
Shares issued for warrants $ 3 (3)    
Common stock issued with debentures, shares 228,903        
Common stock issued with debentures $ 22 582,464     582,486
ASU 2017-11 adjustments to the benefcial conversion feature of convertible debentures   2,551,856     2,551,856
Warrants issued with debt 2,951,429     2,951,429
Common stock issued for the purchase of subsidiaries,shares 175,550        
Common stock issued for the purchase of subsidiaries $ 18 5,587,657     5,587,675
Purchase of treasury stock, shares (255,000)        
Purchase of treasury stock $ (26) (2,260,948)     (2,260,974)
Foreign currency translation adjustment     (184,043)   (184,043)
Net income (loss)       (3,628,757) (3,628,757)
Ending Balance, Amount at Dec. 31, 2018         9,939,403
Ending Balance, Shares at Dec. 31, 2018 9,442,537        
Ending Balance, Amount at Dec. 31, 2018 $ 944 $ 23,962,920 $ (57,431) $ (13,967,030) $ 9,939,403